PROURSAN

This brand name is authorized in Ireland, Poland, Turkey

Active ingredients

The drug PROURSAN contains one active pharmaceutical ingredient (API):

1 Ursodeoxycholic acid UNII 724L30Y2QR - URSODIOL

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones. Read about Ursodeoxycholic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROURSAN Capsule, hard	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A05AA02	Ursodeoxycholic acid	A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100121730, 100386019, 100431441
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699844150983